"With freedom to follow our imagination, we integrate novel cutting edge technologies to create newer, better, safer drugs that will address urgent, unmet needs of patients."
"Our innovative technologies and focused operations significantly shorten drug development time, which lowers R&D costs and increases the commercial lifespan of our drugs."
"Dynamix develops novel drugs that intervene with the metabolism of cancer cells and selectively block kinase signaling pathways in cancer and autoimmune diseases."
Imagination
Speed
Results
"Dynamix is an innovative cancer and autoimmune drug discovery and development biopharmaceutical company focusing on Kinase inhibitors and Cancer Metabolism."
